Epidemiology, virulence factors and management of the pneumococcus - Wikidata - wikimedia - TriplyDB

Epidemiology, virulence factors and management of the pneumococcus

Epidemiology, virulence factors and management of the pneumococcus

http://www.wikidata.org/entity/Q28078832

about

The accessory Sec system (SecY2A2) in Streptococcus pneumoniae is involved in export of pneumolysin toxin, adhesion and biofilm formation.Lectin activity of the pneumococcal pilin proteins.Chemical Composition and Pharmacological Effects of Geopropolis Produced by Melipona quadrifasciata anthidioides.The role of vaccines in preventing bacterial antimicrobial resistance.Ablation of the Leptin receptor in Myeloid Cells Impairs Pulmonary Clearance of Streptococcus Pneumoniae and Alveolar Macrophage Bactericidal Function.Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention.Inflammation and Pneumonia: Why Are Some More Susceptible than Others?

P2860

Q40232601-06363B44-FF39-4ED4-9488-2B0BAEEE6A90 Q47112307-599A5A49-3BD1-46A5-A420-7777033C0FE6 Q47142344-3AA7CABF-F0EC-4FBE-AFAD-E2C605FEE375 Q50120750-7E3B703E-751E-4B76-BDD2-6DFE8303BCB4 Q52643046-C28D98D9-3100-42F2-877E-A7594BF0B419 Q55514832-E7CF7724-8777-4CA7-8245-2D7420591D04 Q58546771-A3D1A70B-3040-4D2A-BC6C-08AA00F96C4C

P2860

Epidemiology, virulence factors and management of the pneumococcus

http://www.wikidata.org/entity/Q28078832

description

2016 nî lūn-bûn

@nan

2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Epidemiology, virulence factors and management of the pneumococcus

@ast

Epidemiology, virulence factors and management of the pneumococcus

@en

Epidemiology, virulence factors and management of the pneumococcus

@nl

type

label

Epidemiology, virulence factors and management of the pneumococcus

@ast

Epidemiology, virulence factors and management of the pneumococcus

@en

Epidemiology, virulence factors and management of the pneumococcus

@nl

prefLabel

Epidemiology, virulence factors and management of the pneumococcus

@ast

Epidemiology, virulence factors and management of the pneumococcus

@en

Epidemiology, virulence factors and management of the pneumococcus

@nl

P1433

Q28078832-944D607A-7E57-4D64-9F3F-1B7E0EE383BF

P1476

Q28078832-5F10E195-65B0-4A3D-8A08-E5C79413E0A4

P2093

Q28078832-7072E1D6-CE87-4933-B6D3-EEE022E27603

Q28078832-C0942759-0DD9-4EAB-B1B5-2BFCE654ECC8

P2860

Q28078832-0044E081-2A53-41EA-9054-FE0A360BF85F

Q28078832-00FA81E7-BCB4-45FC-84C6-677633F4BE2F

Q28078832-063A98CC-58A2-4374-9952-093A6325C352

Q28078832-0666D86E-4A79-42FF-99DE-39976921C80F

Q28078832-06DDDFD1-BD35-4E0A-A737-9AF85FFFF935

Q28078832-06ECFF20-9855-4F5F-8462-6C479E3E16E8

Q28078832-07209274-B16C-45F4-B4FD-21FB918324F8

Q28078832-08634A1F-9D98-4870-8D88-8BEF542F6D5A

Q28078832-0A42C537-B88C-44CE-A866-0D32637CACA9

Q28078832-0B7A0013-B5AD-4702-AB23-7FF00BB57313

P304

Q28078832-39452801-F36D-439D-99A7-F861EE5E40A0

P31

Q28078832-879E0EB1-F887-4937-8A31-C16339D2E51D

P3181

Q28078832-90BF6A2B-8B19-45B4-8CD9-61A67302CCF6

P356

Q28078832-2465B86C-6A64-48E6-AE85-6832B3FB408D

P407

Q28078832-0F0D252D-4291-4D12-8A41-9BC0737D7580

P478

Q28078832-ECB28D7C-AC66-471B-9434-4A874C009E0B

P50

Q28078832-30E87493-88CF-4815-B2C8-79C54F009C33

Q28078832-B6A4207E-9EEA-481B-A0D6-46D85D1927F6

P577

Q28078832-F0ED451F-C5C6-4977-B12E-556F83070001

P698

Q28078832-C3981940-0B55-45DB-A159-96F88AC266CB

P921

Q28078832-8D48BB86-1ECA-4DBE-958B-C426F3FF9059

P932

Q28078832-83B01E34-7A0D-4DD1-B620-7A89F0812CAC

P3181

P356

F1000RESEARCH.9283.1

P1433

P1476

Epidemiology, virulence factors and management of the pneumococcus

@en

P2093

Charles Feldman

http://www.w3.org/2001/XMLSchema#string

Ronald Anderson

http://www.w3.org/2001/XMLSchema#string

P2860

Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia

Clinical and economic burden of community-acquired pneumonia among adults in Europe

Corticosteroids in the adjunctive therapy of community-acquired pneumonia: an appraisal of recent meta-analyses of clinical trials

Nonencapsulated Streptococcus pneumoniae: Emergence and Pathogenesis

Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease

Pneumococcal Capsules and Their Types: Past, Present, and Future

Circulating Pneumolysin Is a Potent Inducer of Cardiac Injury during Pneumococcal Infection

Molecular architecture of Streptococcus pneumoniae surface thioredoxin-fold lipoproteins crucial for extracellular oxidative stress resistance and maintenance of virulence

Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

P304

2320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3524911

http://www.w3.org/2001/XMLSchema#string

P356

10.12688/F1000RESEARCH.9283.1

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Charles Feldman

Ronald Anderson

P577

2016-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27703671

http://www.w3.org/2001/XMLSchema#string

P921

P932

5031122

http://www.w3.org/2001/XMLSchema#string